Erythropoiesis-stimulating Agent [EPC]

53587 reported adverse events

Drugs of this class: DARBEPOETIN ALFA

These side effects are most commonly reported by patients taking drugs of the Erythropoiesis-stimulating Agent [EPC] class:

# Side effect Count
0 DEATH 16131
1 HOSPITALISATION 6182
2 OFF LABEL USE 2583
3 ANAEMIA 2164
4 HAEMOGLOBIN DECREASED 1645
5 PRODUCT STORAGE ERROR 1623
6 PNEUMONIA 1481
7 FATIGUE 1470
8 DYSPNOEA 1432
9 DIARRHOEA 1324
See all common reactions for Erythropoiesis-stimulating Agent [EPC]

Drugs of the Erythropoiesis-stimulating Agent [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VASCULAR ANASTOMOTIC HAEMORRHAGE 24 0.9231
1 APPENDICOLITH 281 0.7493
2 SLEEP DISORDER THERAPY 112 0.6087
3 SHUNT STENOSIS 134 0.4838
4 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE 120 0.4781
5 ANALGESIC THERAPY 124 0.4092
6 ARTERIOVENOUS FISTULA SITE COMPLICATION 238 0.3987
7 DRUG THERAPY 121 0.3829
8 VENA CAVA INJURY 26 0.2955
9 ANTICOAGULANT THERAPY 80 0.2920
See all enriched reactions for Erythropoiesis-stimulating Agent [EPC]